If you're a growth investor, one metric you want to look at is sales growth per share.
"Those increases often reflect the benefit of acquisitions, or they may show companies’ success in growing their core businesses," writes
MarketWatch columnist Philip van Doorn.
He lists the 10 S&P 500 companies with the fastest year-over-year sales growth per share, based on their latest earnings report.
Editor's Note: Seniors Scoop Up Unclaimed $20,500 Checks? (See if You qualify)
| COMPANY |
Sales/Share
Most Recent Qtr |
Sales Growth/Share Year-Over-Year |
| Gilead Sciences |
$3.94 |
142 percent |
| Constellation Brands |
$6.81 |
121 percent |
| Intercontinental Exchange |
$10.33 |
115 percent |
| Devon Energy |
$12.10 |
79 percent |
| Tenet Healthcare |
$41.38 |
76 percent |
| Morgan Stanley |
$6.02 |
60 percent |
| Chesapeake Energy |
$8.61 |
58 percent |
| Facebook |
$1.11 |
54 percent |
| Micron Technology |
$3.35 |
51 percent |
| AmericsourceBergen |
$134.45 |
45 percent |
All but Intercontinental Exchange, Morgan Stanley and Chesapeake Energy have outperformed the S&P 500 so far this year.
Morningstar analyst Karen Andersen heaps high praise on Gilead. "Its focus on infectious disease has paid off in spades," she writes on Morningstar.com.
"With a small salesforce, inexpensive manufacturing and selective research and development, it generates stellar profit margins. And the firm's pipeline is extending its reach into other high-margin markets."
Sales for the company's Sovaldi hepatitis C drug are growing like wildfire. Andersen estimates global Gilead hepatitis C sales of $10.9 billion this year.
To be sure, Gilead's stock is trading near her fair value estimate of $100. The shares stood at $101.99 near midday Wednesday.
Editor's Note: Seniors Scoop Up Unclaimed $20,500 Checks? (See if You qualify)
Related Stories:
© 2026 Newsmax Finance. All rights reserved.